Bayesian Capital Management, LP / DXCM
Bayesian Capital Management, LP’s Dexcom Inc Position
Does Bayesian Capital Management, LP own Dexcom Inc (DXCM)? Not currently — the last reported position was 14.4K shares worth $954,467 in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$954,467
Q4 2025
Shares
14.4K
% of Portfolio
+2.19%
Quarters Held
17
position exited
Position History DXCM
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 14.4K | $954,467 | +2.19% |
| Q3 2025 | 9.4K | $632,526 | +0.13% |
| Q2 2024 | 5.6K | $634,928 | +0.07% |
| Q4 2023 | 54.0K | $7M | +0.71% |
| Q3 2023 | 34.0K | $3M | +0.36% |
| Q2 2023 | 9.8K | $1M | +0.14% |
| Q4 2022 | 8.4K | $951,556 | +0.14% |
| Q2 2022 | 7.0K | $522,000 | +0.10% |
| Q1 2022 | 1.6K | $824,000 | +0.12% |
| Q4 2020 | 6.5K | $2M | +0.63% |
| Q3 2020 | 6.1K | $3M | +0.61% |
| Q2 2020 | 11.5K | $5M | +1.03% |
| Q1 2020 | 13.9K | $4M | +0.81% |
| Q4 2019 | 12.8K | $3M | +0.48% |
| Q2 2019 | 5.0K | $749,000 | +0.15% |
| Q1 2019 | 12.2K | $1M | +0.28% |
| Q4 2018 | 22.0K | $3M | +0.54% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bayesian Capital Management, LP’s full portfolio or all institutional holders of DXCM.